drugset / Trial / NCT06250946
Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
RandomizedParallel-groupDouble-blindOther
Summary
The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in Chinese Obese Subjects.
Timeline
- Start
- 2024-02-23
- Primary completion
- 2025-01-22
- Completion
- 2025-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7535 | Small molecule | 30 mg | Oral |
| Subject | HRS-7535 | Small molecule | 60 mg | Oral |
| Subject | HRS-7535 | Small molecule | 120 mg | Oral |
| Subject | HRS-7535 | Small molecule | 180 mg | Oral |